Incyte Advances Two Cancer Drugs as ESMO Congress Nears

Source Summary

WILMINGTON, DE — Incyte Corp. (Nasdaq: INCY) will present early clinical data on two cancer treatments that have advanced into Phase 3 testing at the ESMO Congress in Madrid this ...